#BEGIN_DRUGCARD DB08272

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C16H17NO4

# Chemical_IUPAC_Name:
(2R,4S)-2-amino-4-(naphthalen-2-ylmethyl)pentanedioic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2010-09-15 15:30:24 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
(4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID

# HET_ID:
NHL

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C16H17NO4/c17-14(16(20)21)9-13(15(18)19)8-10-5-6-11-3-1-2-4-12(11)7-10/h1-7,13-14H,8-9,17H2,(H,18,19)(H,20,21)/t13-,14+/m0/s1

# InChI_Key:
InChIKey=YDWIUFASTTZKNI-UONOGXRCSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
8278

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
287.3105

# Molecular_Weight_Mono:
287.115758037

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.55

# Predicted_LogS:
-3.5

# Predicted_Water_Solubility:
9.01e-02 g/l

# Primary_Accession_No:
DB08272

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
9817372

# PubChem_Substance_ID:
99444743

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@@](N)(C[C@]([H])(CC1=CC2=CC=CC=C2C=C1)C(O)=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:26:39 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE004092

# Drug_Target_1_GenBank_ID_Protein:
13621326

# Drug_Target_1_GeneCard_ID:
murI

# Drug_Target_1_Gene_Name:
murI

# Drug_Target_1_Gene_Sequence:
>1356 bp
ATGACTGAAAATGAACAAATTTTTTGGAACAGGGTCTTGGAATTAGCTCAGAGTCAATTA
AAACAGGCAACTTATGAATTTTTTGTTCATGATGCCCGTCTATTAAAGGTCGATAAGCAT
ATTGCAACTATTTACTTAGATCAAATGAAAGAGCTCTTTTGGGAAAAAAATCTTAAAGAT
GTTATTCTTACTGCTGGTTTTGAAGTTTATAACGCTCAAATTTCTGTTGACTATGTTTTC
GAAGAAGACCTAATGATTGAGCAAAATCAGACCAAAATCAACCAAAAACCTAAGCAGCAA
GCCTTAAATTCTTTGCCTACTGTTACTTCAGATTTAAACTCGAAATATAGTTTTGAAAAC
TTTATTCAAGGAGATGAAAATCGTTGGGCTGTTGCTGCTTCAATAGCAGTAGCTAATACT
CCTGGAACTACCTATAATCCTTTGTTTATTTGGGGTGGCCCTGGGCTTGGAAAAACCCAT
TTATTAAATGCTATTGGTAATTCTGTACTATTAGAAAATCCAAATGCTCGAATTAAATAT
ATCACAGCTGAAAACTTTATTAATGAGTTTGTTATCCATATTCGCCTTGATACCATGGAT
GAATTGAAAGAAAAATTTCGTAATTTAGATTTACTCCTTATTGATGATATCCAATCTTTA
GCTAAAAAAACGCTCTCTGGAACACAAGAAGAGTTCTTTAATACTTTTAATGCACTTCAT
AATAATAACAAACAAATTGTCCTAACAAGCGACCGTACACCAGATCATCTCAATGATTTA
GAAGATCGATTAGTTACTCGTTTTAAATGGGGATTAACAGTCAATATCACACCTCCTGAT
TTTGAAACACGAGTGGCTATTTTGACAAATAAAATTCAAGAATATAACTTTATTTTTCCT
CAAGATACCATTGAGTATTTGGCTGGTCAATTTGATTCTAATGTCAGAGATTTAGAAGGT
GCCTTAAAAGATATTAGTCTGGTTGCTAATTTCAAACAAATTGACACGATTACTGTTGAC
ATTGCTGCCGAAGCTATTCGCGCCAGAAAGCAAGATGGACCTAAAATGACAGTTATTCCC
ATCGAAGAAATTCAAGCGCAAGTTGGAAAATTTTACGGTGTTACCGTCAAAGAAATTAAA
GCTACTAAACGAACACAAAATATTGTTTTAGCAAGACAAGTAGCTATGTTTTTAGCACGT
GAAATGACAGATAACAGTCTTCCTAAAATTGGAAAAGAATTTGGTGGCAGAGACCATTCA
ACAGTACTCCATGCCTATAATAAAATCAAAAACATGATCAGCCAGGACGAAAGCCTTAGG
ATCGAAATTGAAACCATAAAAAACAAAATTAAATAA

# Drug_Target_1_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_1_General_References:
11296296	Ferretti JJ, McShan WM, Ajdic D, Savic DJ, Savic G, Lyon K, Primeaux C, Sezate S, Suvorov AN, Kenton S, Lai HS, Lin SP, Qian Y, Jia HG, Najar FZ, Ren Q, Zhu H, Song L, White J, Yuan X, Clifton SW, Roe BA, McLaughlin R: Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4658-63.
16088826	Sumby P, Porcella SF, Madrigal AG, Barbian KD, Virtaneva K, Ricklefs SM, Sturdevant DE, Graham MR, Vuopio-Varkila J, Hoe NP, Musser JM: Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. J Infect Dis. 2005 Sep 1;192(5):771-82. Epub 2005 Jul 29.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
6771

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
29015.8

# Drug_Target_1_Name:
Glutamate racemase

# Drug_Target_1_Number_of_Residues:
264

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01177	Asp_Glu_race

# Drug_Target_1_Protein_Sequence:
>Glutamate racemase
MDTRPIGFLDSGVGGLTVVCELIRQLPHEKIVYIGDSARAPYGPRPKKQIKEYTWELVNF
LLTQNVKMIVFACNTATAVAWEEVKAALDIPVLGVVLPGASAAIKSTTKGQVGVIGTPMT
VASDIYRKKIQLLAPSIQVRSLACPKFVPIVESNEMCSSIAKKIVYDSLAPLVGKIDTLV
LGCTHYPLLRPIIQNVMGPSVKLIDSGAECVRDISVLLNYFDINGNYHQKAVEHRFFTTA
NPEIFQEIASIWLKQKINVEHVTL

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Provides the (R)-glutamate required for cell wall biosynthesis (By similarity)

# Drug_Target_1_SwissProt_ID:
Q9A1B7

# Drug_Target_1_SwissProt_Name:
MURI_STRP1

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
8.57

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB08272
